Bicycle Therapeutics Ltd (BCYC) — Cash Flow Reinvestment Rate
Latest as of June 2023:
0.02x
Bicycle Therapeutics Ltd (BCYC) has a Cash Flow Reinvestment Rate of 0.02x as of June 2023, reinvesting $554.00K (capex $277.00K plus investments $-277.00K) from operating cash flow of $34.10 Million. Explore Bicycle Therapeutics Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Reinvestment Rate
0.02x
(Capex + Investments) / Operating CF
Total Reinvested
$554.00K
Capex + Investments
Operating Cash Flow
$34.10 Million
USD
Capital Expenditures
$277.00K
USD
Annual Cash Flow Reinvestment Rate for Bicycle Therapeutics Ltd (None–None)
Year-by-year capital reinvestment analysis for Bicycle Therapeutics Ltd. For live market cap and broader valuation context, see BCYC market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow